GO:0046058 cAMP metabolic process: Signaling Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046058 (cAMP metabolic process) describes all chemical reactions and pathways that produce, convert, or degrade cyclic AMP (cAMP), a universal second messenger.
• cAMP is generated from ATP by adenylyl cyclases and degraded by phosphodiesterases; its levels are tightly controlled in space and time.
• cAMP signals through effectors such as PKA, EPAC, and cyclic nucleotide-gated channels, and cross-talks with Ca2+ and AMPK pathways.
• Mitochondrial cAMP metabolism is emerging as a key regulator of oxidative phosphorylation, ROS balance, and steroidogenesis.
• Dysregulated cAMP metabolism contributes to cancer, cardiovascular disease, metabolic disorders, and neurological conditions.
• CRISPR-based knockout, knock-in, and point-mutation models are essential to dissect causal roles of cAMP pathway genes in health and disease.
Description
Cyclic AMP (cAMP) is one of the most ancient and versatile second messengers in eukaryotic cells. The Gene Ontology term GO:0046058, cAMP metabolic process, encompasses the chemical reactions and pathways involving cAMP, including its synthesis from ATP, its conversion to AMP, and its degradation. This process is fundamental to signal transduction, allowing cells to respond to hormones, neurotransmitters, and metabolic cues. cAMP levels are dynamically regulated by adenylyl cyclases (ACs) and phosphodiesterases (PDEs), and its effects are mediated by effectors such as protein kinase A (PKA), exchange proteins directly activated by cAMP (EPAC), and cyclic nucleotide-gated ion channels. Researchers study cAMP metabolism to understand how cells integrate extracellular signals into physiological responses, and how its dysregulation leads to disease. The spatial and temporal organization of cAMP signals, often referred to as nanodomains, is critical for specificity and is an active area of investigation. Moreover, cAMP metabolism intersects with other key pathways, including Ca2+ signaling, AMPK activation, and mitochondrial function, making it a central node in cellular homeostasis.
cAMP metabolic process At A Glance
| GO ID | GO:0046058 |
|---|---|
| GO term | cAMP metabolic process |
| Ontology | biological_process |
| Synonym | cyclic AMP metabolic process; 3',5'-cAMP metabolism; adenosine 3',5'-cyclophosphate metabolic process |
| Major function | Synthesis, degradation, and interconversion of cAMP, a key second messenger |
| Key enzymes | Adenylyl cyclases (ADCY1-10), phosphodiesterases (PDE1-11) |
| Key effectors | PKA, EPAC, CNG channels |
| Subcellular locations | Plasma membrane, cytosol, mitochondria, nucleus |
| Related pathways | GPCR signaling, AMPK signaling, Ca2+ signaling, insulin secretion |
What Is GO:0046058?
According to the Gene Ontology, GO:0046058 (cAMP metabolic process) is defined as the chemical reactions and pathways involving the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate). This includes the biosynthesis of cAMP from ATP by adenylyl cyclases, the hydrolysis of cAMP to 5'-AMP by phosphodiesterases, and any interconversion or transport steps that regulate intracellular cAMP concentrations. The term also covers the metabolic fate of cAMP and its role as a signaling molecule, though signaling per se is often annotated separately.
Why Is cAMP metabolic process Important in Cell Biology?
cAMP metabolic process is essential for virtually all physiological responses to hormones and neurotransmitters, including cardiac contractility, neuronal plasticity, immune function, and metabolic regulation. Dysregulation of cAMP synthesis or degradation is implicated in cancer, heart failure, diabetes, and neurodegenerative diseases. Understanding the precise molecular steps and regulatory mechanisms of cAMP metabolism provides a foundation for developing targeted therapeutics, such as PDE inhibitors and adenylyl cyclase modulators.
• cAMP is a universal second messenger that mediates responses to numerous hormones and neurotransmitters.
• cAMP metabolism is spatially compartmentalized, enabling signal specificity in different subcellular domains.
• Mitochondrial cAMP regulates oxidative phosphorylation, ROS production, and steroidogenesis.
• cAMP cross-talks with Ca2+ signaling, AMPK, and sirtuins to control metabolic health.
• Altered cAMP metabolism is linked to cardiovascular diseases, including heart failure and arrhythmias.
• cAMP pathway mutations cause endocrine disorders such as Cushing's syndrome and McCune-Albright syndrome.
• cAMP signaling is critical for immune cell function and inflammation.
• Phosphodiesterases are major drug targets; their inhibition modulates cAMP levels in various diseases.
• cAMP metabolism influences neuronal excitability and synaptic plasticity.
• CRISPR screens can identify novel regulators of cAMP metabolism and its downstream effects.
What Happens During cAMP metabolic process?
Synthesis of cAMP from ATP
In simple terms: Cells make cAMP by cutting a phosphate group from ATP using enzymes called adenylyl cyclases.
Adenylyl cyclases (ACs) catalyze the conversion of ATP to cAMP and pyrophosphate. This reaction is stimulated by G-protein coupled receptor (GPCR) signaling via Gs alpha subunits and inhibited by Gi alpha subunits. Multiple AC isoforms (ADCY1-10) exhibit distinct tissue distribution and regulatory properties, allowing cell-type-specific cAMP production. The activity of ACs is also modulated by Ca2+/calmodulin, forskolin, and other factors, contributing to signal integration.
Degradation of cAMP by phosphodiesterases
In simple terms: Enzymes called phosphodiesterases break down cAMP into AMP, stopping the signal.
Phosphodiesterases (PDEs) hydrolyze the 3',5'-cyclic phosphate bond of cAMP to produce 5'-AMP. The PDE superfamily comprises 11 families (PDE1-11), each with distinct substrate specificity, regulation, and localization. PDEs are crucial for terminating cAMP signals and shaping their spatial and temporal dynamics. For example, PDE4 and PDE3 are major regulators of cAMP in cardiac and metabolic tissues, and their inhibition is a therapeutic strategy.
Compartmentalization and nanodomains
In simple terms: cAMP signals are not uniform; they are concentrated in tiny local areas within cells.
cAMP signaling is highly compartmentalized, with distinct pools of cAMP acting in different subcellular locations. This is achieved through the coordinated action of ACs, PDEs, and A-kinase anchoring proteins (AKAPs). Nanodomains of cAMP allow specific effectors to be activated locally, influencing processes such as cardiac myocyte contraction and neuronal signaling. Imaging techniques have revealed that cAMP gradients can be dynamically regulated in space and time.
Mitochondrial cAMP metabolism
In simple terms: Mitochondria have their own cAMP signaling that helps control energy production and cell survival.
Mitochondria contain a distinct cAMP pool that regulates oxidative phosphorylation, ROS production, and apoptosis. Soluble adenylyl cyclase (sAC) and mitochondrial PDEs modulate this pool. Mitochondrial cAMP cross-talks with Ca2+ signaling and is important for steroidogenesis in adrenocortical cells. This mitochondrial cAMP metabolism is linked to mitohormesis and metabolic health.
Cross-talk with other signaling pathways
In simple terms: cAMP does not act alone; it communicates with other cellular signals like calcium and AMPK.
cAMP signaling intersects with Ca2+ signaling, AMPK activation, and sirtuin pathways. For instance, cAMP can modulate AMPK activity, and AMPK can feedback to regulate cAMP levels, creating a complex network that controls energy balance. In mitochondria, cAMP and Ca2+ cross-talk regulates dehydrogenase activity and ATP production. These interactions are critical for integrating metabolic and stress signals.
Key Genes Involved in GO:0046058 cAMP metabolic process
The following genes encode key enzymes and effectors involved in cAMP metabolic process, with representative roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADCY1 | Adenylyl cyclase isoform 1; synthesizes cAMP | Neuronal signaling, memory formation |
| ADCY5 | Adenylyl cyclase isoform 5; synthesizes cAMP | Cardiac and metabolic regulation |
| ADCY6 | Adenylyl cyclase isoform 6; synthesizes cAMP | Cardiovascular function |
| ADCY9 | Adenylyl cyclase isoform 9; synthesizes cAMP | Immune response, cancer |
| PDE1 | Phosphodiesterase family 1; degrades cAMP | Cardiovascular disease, neurodegeneration |
| PDE3 | Phosphodiesterase family 3; degrades cAMP | Heart failure, metabolic disorders |
| PDE4 | Phosphodiesterase family 4; degrades cAMP | Inflammation, depression, COPD |
| PDE8 | Phosphodiesterase family 8; degrades cAMP | Steroidogenesis, cancer |
| PRKACA | Catalytic subunit of PKA; effector of cAMP | Cushing's syndrome, cancer |
| PRKAR1A | Regulatory subunit of PKA; binds cAMP | Carney complex, endocrine tumors |
| EPAC1 (RAPGEF3) | Exchange protein activated by cAMP | Cell adhesion, insulin secretion |
| EPAC2 (RAPGEF4) | Exchange protein activated by cAMP | Neuronal signaling, diabetes |
| CNGA1 | Cyclic nucleotide-gated channel; responds to cAMP | Vision, olfactory signaling |
| AKAP5 | A-kinase anchoring protein; localizes PKA | Cardiac function, synaptic plasticity |
| CREB1 | Transcription factor activated by cAMP/PKA | Gene expression, memory, metabolism |
| sAC (ADCY10) | Soluble adenylyl cyclase; synthesizes cAMP | Mitochondrial function, steroidogenesis |
| GNAI1 | Inhibitory G protein alpha subunit; inhibits AC | Signal termination, cancer |
| GNAS | Stimulatory G protein alpha subunit; activates AC | McCune-Albright syndrome, obesity |
How Is cAMP metabolic process Regulated?
cAMP metabolic process is regulated at multiple levels. Adenylyl cyclases are controlled by G-protein coupled receptors (GPCRs), Ca2+/calmodulin, and phosphorylation. Phosphodiesterases are regulated by phosphorylation, Ca2+/calmodulin, and cGMP competition, and their activity shapes cAMP gradients. Compartmentalization by AKAPs and PDEs ensures localized signaling. Feedback loops involving PKA and EPAC modulate upstream components. Additionally, mitochondrial cAMP metabolism is regulated by sAC and mitochondrial PDEs, and cross-talks with Ca2+ and ROS.
cAMP metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GNAS | McCune-Albright syndrome, pituitary adenomas | Knock-in point mutation (R201C) in cell lines |
| PRKACA | Cushing's syndrome, adrenal hyperplasia | Knockout and point mutation in adrenal cells |
| PDE4 | Inflammation, depression, COPD | Knockout mice and overexpression cell models |
| ADCY5 | Type 2 diabetes, obesity | Knock-in point mutation in pancreatic beta cells |
| sAC (ADCY10) | Male infertility, mitochondrial dysfunction | Knockout in sperm cells and mitochondria |
Cancer
Dysregulated cAMP signaling contributes to cancer through altered proliferation, apoptosis, and migration. Mutations in GNAS (encoding Gs alpha) lead to constitutive adenylyl cyclase activation and are found in various tumors, including pituitary adenomas and fibrous dysplasia. Overexpression of PDEs or loss of PKA regulatory subunits can also promote oncogenesis. Targeting cAMP metabolism is a therapeutic strategy in some cancers.
Cardiovascular disease
cAMP is central to cardiac contractility and rhythm. Altered cAMP compartmentation and PDE activity are implicated in heart failure and arrhythmias. PDE3 inhibitors are used for heart failure, while PDE4 inhibitors are investigated for cardiovascular inflammation. Mitochondrial cAMP dysfunction contributes to cardiac ischemia-reperfusion injury.
Metabolic disorders
cAMP metabolism regulates insulin secretion, lipolysis, and glucose homeostasis. Mutations in ADCY5 are associated with type 2 diabetes and obesity. PDE inhibitors are explored for metabolic syndrome. cAMP/AMPK cross-talk is critical for energy balance, and its disruption leads to insulin resistance.
Neurological and psychiatric disorders
cAMP signaling is essential for synaptic plasticity, memory, and mood regulation. PDE4 inhibitors are investigated for depression and cognitive disorders. Astroglial cAMP signaling modulates neuronal activity and is implicated in neurodegeneration. Mitochondrial cAMP dysfunction may contribute to neurodegenerative diseases.
From cAMP metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ADCY5 affect glucose-stimulated insulin secretion? | ADCY5 knockout pancreatic beta cell line |
| Does the GNAS R201C mutation cause constitutive cAMP elevation? | GNAS R201C knock-in HEK293 cells |
| How does PDE4 inhibition affect inflammatory cytokine production? | PDE4 knockout macrophages and overexpression models |
| What is the role of mitochondrial sAC in steroidogenesis? | sAC knockout adrenocortical cells |
| Does PRKACA mutation alter PKA activity and cortisol production? | PRKACA point-mutation knock-in adrenal cells |
| Can EPAC1 overexpression rescue cAMP-mediated cell adhesion? | EPAC1 overexpression in fibroblasts |
How to Study the cAMP metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| FRET-based cAMP sensors | Real-time cAMP concentration and dynamics | Live-cell imaging of compartmentalized signaling |
| PDE activity assay | Phosphodiesterase enzymatic activity | Drug screening, mutant characterization |
| CRISPR knockout screen | Genes affecting cAMP levels or signaling | Discovery of novel regulators |
| Phosphoproteomics | PKA substrate phosphorylation | Mapping signaling networks |
| RNA-seq | Transcriptional changes downstream of cAMP | CREB target gene analysis |
| Mitochondrial respiration assay | Oxidative phosphorylation and ROS | Mitochondrial cAMP function |
| cAMP ELISA | Total intracellular cAMP levels | High-throughput compound screening |
Genetically encoded cAMP sensors
Fluorescent biosensors (e.g., EPAC-based, PKA-based) allow real-time imaging of cAMP dynamics in live cells with subcellular resolution. These sensors have revealed cAMP nanodomains and compartmentalized signaling in cardiac myocytes and neurons.
Phosphodiesterase activity assays
PDE activity can be measured using radioactive or fluorescent substrates to determine hydrolysis rates. These assays are used to evaluate PDE inhibitors and to characterize mutant PDEs.
CRISPR screening for cAMP regulators
Genome-wide CRISPR knockout or activation screens coupled with cAMP-responsive reporters can identify novel genes that regulate cAMP levels or downstream signaling. This approach has uncovered modulators of GPCR-cAMP pathways.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify changes in protein phosphorylation downstream of cAMP/PKA. This helps map signaling networks and identify substrates of PKA and EPAC.
How CRISPR Can Be Used to Study GO:0046058 cAMP metabolic process
Knockout
CRISPR knockout of genes encoding adenylyl cyclases, phosphodiesterases, or PKA subunits can abolish or alter cAMP metabolism. For example, ADCY5 knockout cells show impaired glucose-stimulated insulin secretion, and PDE4 knockout macrophages exhibit elevated cAMP and reduced inflammation.
Point Mutation
Point mutations can mimic disease-associated variants, such as GNAS R201C or PRKACA L206R, to study constitutive activation of cAMP signaling. These models help dissect the molecular mechanisms of endocrine tumors and other disorders.
Knock-in
Knock-in of tagged versions of cAMP pathway proteins (e.g., GFP-tagged PDE4) allows real-time imaging and localization studies. Knock-in of reporter genes under cAMP-responsive promoters (e.g., CRE-luciferase) enables monitoring of pathway activity.
Overexpression
Overexpression of wild-type or mutant forms of adenylyl cyclases, PDEs, or EPAC can elevate or dampen cAMP signals. This is useful to test gain-of-function effects and to validate drug targets.
How EDITGENE Supports cAMP metabolic process Research
Researchers studying cAMP metabolic process-related genes often need to determine whether a candidate gene is causally involved in cAMP regulation, signal transduction, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for cAMP metabolic process research.
Frequently Asked Questions About cAMP metabolic process
What is cAMP metabolic process?
cAMP metabolic process (GO:0046058) encompasses the chemical reactions and pathways that synthesize, degrade, and interconvert cyclic AMP, a key second messenger.
What genes are involved in cAMP metabolic process?
Key genes include adenylyl cyclases (ADCY1-10), phosphodiesterases (PDE1-11), PKA subunits (PRKACA, PRKAR1A), EPACs (RAPGEF3, RAPGEF4), and G proteins (GNAS, GNAI1).
How is cAMP synthesized and degraded?
cAMP is synthesized from ATP by adenylyl cyclases and degraded to AMP by phosphodiesterases.
Why is cAMP important in the heart?
cAMP regulates cardiac contractility and rhythm; its compartmentalization is critical for normal heart function, and dysregulation leads to heart failure.
What diseases are associated with cAMP metabolism?
Cancer, cardiovascular disease, metabolic disorders, and neurological conditions are linked to altered cAMP metabolism.
How can I study cAMP metabolic process in the lab?
Use genetically encoded sensors, PDE activity assays, CRISPR screens, and phosphoproteomics to measure cAMP dynamics and downstream effects.
What are cAMP nanodomains?
cAMP nanodomains are localized pools of cAMP that enable specific signaling in subcellular compartments, often organized by AKAPs and PDEs.
Does mitochondrial cAMP metabolism differ from cytosolic?
Yes, mitochondria have a distinct cAMP pool regulated by soluble adenylyl cyclase and mitochondrial PDEs, affecting oxidative phosphorylation and steroidogenesis.
What CRISPR models are available for cAMP research?
Knockout, point mutation knock-in, tagged knock-in, and overexpression models can be generated for any cAMP pathway gene.
How does cAMP cross-talk with AMPK?
cAMP and AMPK signaling intersect to regulate energy balance; AMPK can modulate cAMP levels and vice versa, influencing metabolic homeostasis.
Conclusion
cAMP metabolic process (GO:0046058) is a fundamental biological process that controls diverse cellular functions through the synthesis and degradation of cyclic AMP. Its dysregulation underlies numerous diseases, making it a prime target for therapeutic intervention. Advanced CRISPR models and imaging techniques continue to unravel the complexities of cAMP signaling, offering new opportunities for drug discovery. EDITGENE provides essential tools to study this pathway and accelerate research.
References
- 1. Aslam M et al.. 2022. Emerging Role of cAMP/AMPK Signaling.. Cells 11(2) PMID: 35053423
- 2. Wu G et al.. 2025. Lactylation of CREB is required for FSH-induced proliferation and differentiation of ovarian granulosa cells.. Nucleic Acids Res 53(17) PMID: 40966521
- 3. Mukhopadhyay S et al.. 1998. Role of protein phosphatases in cyclic AMP-mediated stimulation of hepatic Na+/taurocholate cotransport.. J Biol Chem 273(45):30039-45 PMID: 9792726
- 4. Chao YC et al.. 2019. Imaging cAMP nanodomains in the heart.. Biochem Soc Trans 47(5):1383-1392 PMID: 31670375
- 5. Palmeira CM et al.. 2019. Mitohormesis and metabolic health: The interplay between ROS, cAMP and sirtuins.. Free Radic Biol Med 141:483-491 PMID: 31349039
- 6. Di Benedetto G et al.. 2014. Ca2+ and cAMP cross-talk in mitochondria.. J Physiol 592(2):305-12 PMID: 23858012
- 7. Horvat A et al.. 2019. Astroglial cAMP signalling in space and time.. Neurosci Lett 689:5-10 PMID: 29908259
- 8. Spät A et al.. 2018. Mitochondrial cAMP and Ca(2+) metabolism in adrenocortical cells.. Pflugers Arch 470(8):1141-1148 PMID: 29876637
